Intel’s latest earnings report justified its recent stock surge — and then some. The stock is due to see a potentially historic gain in Friday’s session, judging by Thursday’s after-hours action.

An online tracker that measures the extent to which Project 2025 has been implemented by the government has hit a 50 per cent milestone. According to a website created by two Reddit users, titled ...

Nvidia (NVDA) retook the $5 trillion market cap crown on Friday, according to Yahoo Finance data, as a powerful rally in chip stocks encouraged by Intel (INTC) earnings and a nuclear power deal with ...

While Nvidia's revenue is growing quickly, its success is not reflected in the stock price. The chipmaker's shares are undervalued compared to their three-year mean price. Keep an eye on capital ...

Shares of Charter Communications were on pace for their largest percentage decrease on record Friday after the company reported earnings below expectations and declines in video and internet ...

AUBURN — Alex Golesh's time on the Plains hit a notable mile-marker Saturday, April 18, as Auburn football hosted its annual A-Day spring game, and it saw the offense emerge victorious in a 66-43 ...

The EU is moving forward with a plan to restrict funding for PV projects using inverters from high-risk suppliers, citing cybersecurity concerns and issuing new guidance to phase them out. A ...

Intel shares could see their best post-earnings performance on record and finally surpass their 2000 closing high amid a 'CPU renaissance' Intel is benefiting from a flood of demand for server CPUs.

DURHAM - Exeter High School senior Lexi Paterna won two events at the six-team Oyster River Spring Classic on Saturday, April 18. Paterna won the 800 (2 minutes, 18.62 seconds) and the 1,600 (5:01.32) ...

Thailand will press ahead with a long-standing plan to link the Indian and Pacific oceans, bypassing the Malacca Strait, after tensions over the Strait of Hormuz highlighted the strategic value of key ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...